Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 912.38 million compared to CNY 890.33 million a year ago. Revenue was CNY 916.06 million compared to CNY 891.84 million a year ago.

Net income was CNY 167.62 million compared to CNY 134.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.3331 compared to CNY 0.268 a year ago. Diluted earnings per share from continuing operations was CNY 0.3331 compared to CNY 0.268 a year ago.